Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)

INTRODUCTION: Hereditary transthyretin amyloidosis (ATTRv amyloidosis) is a clinically heterogeneous disease caused by mutations in the transthyretin (TTR) gene. The most common mutation, Val30Met, can manifest as an early- or late-onset disease. METHODS: The Transthyretin Amyloidosis Outcomes Surve...

Descripción completa

Detalles Bibliográficos
Autores principales: Waddington-Cruz, Márcia, Wixner, Jonas, Amass, Leslie, Kiszko, Jan, Chapman, Doug, Ando, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571445/
https://www.ncbi.nlm.nih.gov/pubmed/34024024
http://dx.doi.org/10.1007/s40120-021-00258-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571445/
https://www.ncbi.nlm.nih.gov/pubmed/34024024
http://dx.doi.org/10.1007/s40120-021-00258-z

Ejemplares similares